US Stocks
/
AbCellera Biologics Inc. Share Price

AbCellera Biologics Inc. Share Price

NASDAQ: ABCL | Small Cap
$6.58
+$0.07 (1.00%) Last updated on 07 Aug, 2026 | 23:35 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

AbCellera Biologics Inc. Stock Performance

Open
$6.66
Prev. Close
$6.51
Circuit Range
N/A
Day Range
$6.36 - $6.66
Year Range
$2.75 - $8.41
Volume
1,56,135
Average Traded
$6.46

AbCellera Biologics Inc. Share Price Today

As of 9 August 2026, AbCellera Biologics Inc.'s share price is $6.58. The stock opened at $6.66, compared to its previous close of $6.51. During today's trading session, AbCellera Biologics Inc.'s share price traded between $6.36 and $6.66, with an average price of $6.51. Over the past 52 weeks, the stock has recorded a high of $8.41 and a low of $2.75. In terms of performance, AbCellera Biologics Inc.'s share price has risen by 82.78% over the last six months and is up 57.79% on a year-on-year basis.

AbCellera Biologics Inc. Share Price Chart

$6.36$6.66
L
Show Current Price
H

AbCellera Biologics Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.97B
PE Ratio (TTM)
-13.43
Dividend Yield
N/A
EPS (TTM)
$-0.49
Revenue (TTM)
$75.13M
Return On Equity (TTM)
-15.14%
Profit Margin
-194.88%
Debt to Equity
0.07
Quarterly Earnings Growth YoY
-11.76%

AbCellera Biologics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$7.32M$6.51M$4.24M$17.08M$8.96M
Net Profit-$40.61M-$36.93M-$51.11M-$45.62M-$34.73M-$57.12M
Net Profit MarginN/A-504.30%-785.42%-1077.24%-203.27%-637.84%
Income ChangeN/A9.06%-38.39%10.73%23.88%-64.48%

AbCellera Biologics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$485.42M$38.02M$28.83M$75.13M
Net Profit$158.52M-$146.40M-$162.86M-$146.41M
Net Profit Margin32.66%-385.00%-564.83%-194.88%
Income ChangeN/A-192.35%-11.24%10.10%

About AbCellera Biologics Inc.

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$5.68
$6.58
+15.15%
Jul 2026
$7.78
$5.71
-27.17%
Jun 2026
$6.13
$7.84
+26.86%
May 2026
$4.13
$6.18
+48.74%
Apr 2026
$3.53
$4.16
+18.88%
Mar 2026
$3.48
$3.50
-2.92%
Feb 2026
$3.56
$3.60
-0.55%
Jan 2026
$3.46
$3.62
+6.16%
Dec 2025
$3.58
$3.41
-8.82%
Nov 2025
$5.54
$3.74
-32.49%
Oct 2025
$5.08
$5.54
+10.25%
Sep 2025
$4.13
$5.03
+20.50%

ABCL Share Price FAQs

What is AbCellera Biologics Inc. share price today?

chevron-up
AbCellera Biologics Inc. share price today is $6.58 as on August 7, 2026 at 11:35 pm IST.

What is the 52 week high and 52 week low of AbCellera Biologics Inc. stock?

chevron-up
The 52 week high of AbCellera Biologics Inc. stock is $8.41, while the 52 week low is $2.75 as of 7 Aug '26.

What is ABCL's market capitalisation today?

chevron-up
ABCL market capitalisation is $1.97B as of August 9, 2026, at 8:00 am IST.

What is ABCL's net income for the last quarter?

chevron-up
ABCL's net income for the last quarter is -0.06B USD.

What is the 5 year returns of ABCL?

chevron-up
The 5 year returns of ABCL is -60.74% as on 7 Aug '26.

What is the high & low stock price of ABCL today?

chevron-up
ABCL stock price hit a high of $6.66 and low of $6.36 as of 7 Aug '26.

Can I buy ABCL shares in India?

chevron-up
Yes. You can buy ABCL in India by opening an international trading account.